Skip to main content

1 Result(s)

within English Remove this filter Medicine & Public Health Remove this filter Hematology Remove this filter J. Raphael Remove this filter

and

  1. No Access

    Article

    Should BRCA2 mutation carriers avoid neoadjuvant chemotherapy?

    BRCA2 mutation carriers typically develop luminal B breast cancers. Data on the effectiveness of neoadjuvant chemotherapy in these patients are limited because of small patient numbers and lack of prospective ...

    J. Raphael, C. Mazouni, O. Caron, M. Ferchiou, S. Delaloge in Medical Oncology (2014)